JMVNX
Price
$18.57
Change
-$0.09 (-0.48%)
Updated
Sep 20 closing price
JVMIX
Price
$30.42
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
Ad is loading...

JMVNX vs JVMIX

Header iconJMVNX vs JVMIX Comparison
Open Charts JMVNX vs JVMIXBanner chart's image
JHFunds2 Mid Value NAV
Price$18.57
Change-$0.09 (-0.48%)
VolumeN/A
CapitalizationN/A
JHancock Disciplined Value Mid Cap I
Price$30.42
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JMVNX vs JVMIX Comparison Chart
Loading...
VS
JMVNX vs. JVMIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVNX is a StrongBuy and JVMIX is a Buy.

FUNDAMENTALS
Fundamentals
JVMIX has more cash in the bank: 23.4B vs. JMVNX (1.5B). JMVNX pays higher dividends than JVMIX: JMVNX (1.08) vs JVMIX (0.84). JMVNX was incepted earlier than JVMIX: JMVNX (16 years) vs JVMIX (27 years). JMVNX is a more actively managed with annual turnover of: 55.00 vs. JVMIX (41.00). JMVNX has a lower initial minimum investment than JVMIX: JMVNX (0) vs JVMIX (250000). JMVNX (19.92) and JVMIX (19.46) have marching annual gain over last year. JVMIX return over 5 years is better than : 44.34 vs. JMVNX (32.04).
JMVNXJVMIXJMVNX / JVMIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years27 years-
Gain YTD16.40711.144147%
Front LoadN/AN/A-
Min. Initial Investment0250000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.5B23.4B6%
Annual Yield % from dividends1.080.84129%
Returns for 1 year19.9219.46102%
Returns for 3 years2.7813.7320%
Returns for 5 years32.0444.3472%
Returns for 10 years16.7464.8726%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTBT3.170.12
+3.93%
Bit Digital
JHG38.190.08
+0.21%
Janus Henderson Group plc
LTRN3.99-0.08
-1.97%
Lantern Pharma
DHI191.89-5.17
-2.62%
DR Horton
IRWD4.30-0.20
-4.55%
Ironwood Pharmaceuticals